ArticleInternational journal of oncology2020

Inhibiting the NF-κB pathway enhances the antitumor effect of cabazitaxel by downregulating Bcl-2 in pancreatic cancer.

Zequn Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.